Lymphatic and Angiogenic Candidate Genes Predict the Development of Secondary Lymphedema Following Breast Cancer Surgery

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2013 Apr 25

PMID 23613720

Citations 57

Authors

Christine Miaskowski

Marylin Dodd

Steven M Paul

Claudia West

Deborah Hamolsky

Gary Abrams

Bruce A Cooper

Charles Elboim

John Neuhaus

Brian L Schmidt

Betty Smoot

Bradley E Aouizerat

Affiliations

Soon will be listed here.

Abstract

The purposes of this study were to evaluate for differences in phenotypic and genotypic characteristics in women who did and did not develop lymphedema (LE) following breast cancer treatment. Breast cancer patients completed a number of self-report questionnaires. LE was evaluated using bioimpedance spectroscopy. Genotyping was done using a custom genotyping array. No differences were found between patients with (n = 155) and without LE (n = 387) for the majority of the demographic and clinical characteristics. Patients with LE had a significantly higher body mass index, more advanced disease and a higher number of lymph nodes removed. Genetic associations were identified for four genes (i.e., lymphocyte cytosolic protein 2 (rs315721), neuropilin-2 (rs849530), protein tyrosine kinase (rs158689), vascular cell adhesion molecule 1 (rs3176861)) and three haplotypes (i.e., Forkhead box protein C2 (haplotype A03), neuropilin-2 (haplotype F03), vascular endothelial growth factor-C (haplotype B03)) involved in lymphangiogensis and angiogenesis. These genetic associations suggest a role for a number of lymphatic and angiogenic genes in the development of LE following breast cancer treatment.

Citing Articles

Immediate lymphatic reconstruction for the prevention of breast cancer-related lymphedema: an experience highlighting the importance of lymphatic anatomy.

Friedman R, Kinney J, Bahadur A, Singhal D Plast Aesthet Res. 2024; 10.

PMID: 39640842 PMC: 11619053. DOI: 10.20517/2347-9264.2022.100.

Contribution of Endothelial Dysfunction to Cancer Susceptibility and Progression: A Comprehensive Narrative Review on the Genetic Risk Component.

de Melo I, Tavares V, Pereira D, Medeiros R Curr Issues Mol Biol. 2024; 46(5):4845-4873.

PMID: 38785560 PMC: 11120512. DOI: 10.3390/cimb46050292.

Demystifying vascularized lymph node transfers and lymphatico-venous anastomoses.

Almadani Y, Davison P, Efanov J, Kokosis G, Vorstenbosch J Ann Transl Med. 2024; 12(1):8.

PMID: 38304897 PMC: 10777230. DOI: 10.21037/atm-23-132.

Dysregulation of Lymphatic Endothelial VEGFR3 Signaling in Disease.

Kuonqui K, Campbell A, Sarker A, Roberts A, Pollack B, Park H Cells. 2024; 13(1).

PMID: 38201272 PMC: 10778007. DOI: 10.3390/cells13010068.

Etiology and treatment of cancer-related secondary lymphedema.

Bernas M, Al-Ghadban S, Thiadens S, Ashforth K, Lin W, Safa B Clin Exp Metastasis. 2023; 41(4):525-548.

PMID: 37777696 DOI: 10.1007/s10585-023-10232-8.

References

Gabriel S, Schaffner S, Nguyen H, Moore J, Roy J, Blumenstiel B . The structure of haplotype blocks in the human genome. Science. 2002; 296(5576):2225-9. DOI: 10.1126/science.1069424. View

Stamatakos M, Michael S, Stefanaki C, Charikleia S, Kontzoglou K, Konstantinos K . Lymphedema and breast cancer: a review of the literature. Breast Cancer. 2011; 18(3):174-80. DOI: 10.1007/s12282-010-0246-1. View

Saito Y, Nakagami H, Morishita R, Takami Y, Kikuchi Y, Hayashi H . Transfection of human hepatocyte growth factor gene ameliorates secondary lymphedema via promotion of lymphangiogenesis. Circulation. 2006; 114(11):1177-84. DOI: 10.1161/CIRCULATIONAHA.105.602953. View

Hattersley A, McCarthy M . What makes a good genetic association study?. Lancet. 2005; 366(9493):1315-23. DOI: 10.1016/S0140-6736(05)67531-9. View

Yuan L, Moyon D, Pardanaud L, Breant C, Karkkainen M, Alitalo K . Abnormal lymphatic vessel development in neuropilin 2 mutant mice. Development. 2002; 129(20):4797-806. DOI: 10.1242/dev.129.20.4797. View

Alitalo K . The lymphatic vasculature in disease. Nat Med. 2011; 17(11):1371-80. DOI: 10.1038/nm.2545. View

Finegold D, Baty C, Knickelbein K, Perschke S, Noon S, Campbell D . Connexin 47 mutations increase risk for secondary lymphedema following breast cancer treatment. Clin Cancer Res. 2012; 18(8):2382-90. PMC: 3625665. DOI: 10.1158/1078-0432.CCR-11-2303. View

Traboulsi E, Matsumoto M, Kimak M, Crowe S, Wilson S, Finegold D . Lymphedema-distichiasis syndrome and FOXC2 gene mutation. Am J Ophthalmol. 2002; 134(4):592-6. DOI: 10.1016/s0002-9394(02)01642-2. View

Conde L, Vaquerizas J, Dopazo H, Arbiza L, Reumers J, Rousseau F . PupaSuite: finding functional single nucleotide polymorphisms for large-scale genotyping purposes. Nucleic Acids Res. 2006; 34(Web Server issue):W621-5. PMC: 1538854. DOI: 10.1093/nar/gkl071. View

10.

Butler M, Isogai S, Weinstein B . Lymphatic development. Birth Defects Res C Embryo Today. 2009; 87(3):222-31. PMC: 2755610. DOI: 10.1002/bdrc.20155. View

11.

Staton C, Kumar I, Reed M, Brown N . Neuropilins in physiological and pathological angiogenesis. J Pathol. 2007; 212(3):237-48. DOI: 10.1002/path.2182. View

12.

Jurisic G, Detmar M . Lymphatic endothelium in health and disease. Cell Tissue Res. 2008; 335(1):97-108. DOI: 10.1007/s00441-008-0644-2. View

13.

Kerjaschki D, Regele H, Moosberger I, Nagy-Bojarski K, Watschinger B, Soleiman A . Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphocytic infiltrates. J Am Soc Nephrol. 2004; 15(3):603-12. DOI: 10.1097/01.asn.0000113316.52371.2e. View

14.

Dagenais S, Hartsough R, Erickson R, Witte M, Butler M, Glover T . Foxc2 is expressed in developing lymphatic vessels and other tissues associated with lymphedema-distichiasis syndrome. Gene Expr Patterns. 2004; 4(6):611-9. DOI: 10.1016/j.modgep.2004.07.004. View

15.

Mellor R, Brice G, Stanton A, French J, Smith A, Jeffery S . Mutations in FOXC2 are strongly associated with primary valve failure in veins of the lower limb. Circulation. 2007; 115(14):1912-20. DOI: 10.1161/CIRCULATIONAHA.106.675348. View

16.

Wang Y, Oliver G . Current views on the function of the lymphatic vasculature in health and disease. Genes Dev. 2010; 24(19):2115-26. PMC: 2947764. DOI: 10.1101/gad.1955910. View

17.

Dhruva A, Paul S, Cooper B, Lee K, West C, Aouizerat B . A longitudinal study of measures of objective and subjective sleep disturbance in patients with breast cancer before, during, and after radiation therapy. J Pain Symptom Manage. 2012; 44(2):215-28. PMC: 3414693. DOI: 10.1016/j.jpainsymman.2011.08.010. View

18.

Armer J . Research on risk assessment for secondary lymphedema following breast cancer treatment. Cancer Epidemiol Biomarkers Prev. 2010; 19(11):2715-7. DOI: 10.1158/1055-9965.EPI-10-0962. View

19.

Stephens M, Smith N, Donnelly P . A new statistical method for haplotype reconstruction from population data. Am J Hum Genet. 2001; 68(4):978-89. PMC: 1275651. DOI: 10.1086/319501. View

20.

Sebzda E, Hibbard C, Sweeney S, Abtahian F, Bezman N, Clemens G . Syk and Slp-76 mutant mice reveal a cell-autonomous hematopoietic cell contribution to vascular development. Dev Cell. 2006; 11(3):349-61. DOI: 10.1016/j.devcel.2006.07.007. View